XML 31 R15.htm IDEA: XBRL DOCUMENT
v3.25.1

Share-Based Compensation | 12 Months Ended
--- | ---
Feb. 01, 2025 | Feb. 03, 2024
Share-Based Payment Arrangement [Abstract] |  |
Share-Based Compensation | Share-Based Compensation Equity Incentive Plan Pursuant to the Company's 2022 Equity Incentive Plan (the “Plan”), the Company’s Board of Directors may grant stock options, restricted shares and restricted stock units to officers, directors, key crew and professional service providers. The Plan allows for the issuance of up to a total of 4.3 million shares under the Plan. As of February 1, 2025, approximately 3.2 million stock options, restricted shares, or restricted stock units were available for grant. Common Stock Options All stock options have a term not greater than ten years. Stock options vest and become exercisable in whole or in part, in accordance with vesting conditions set by the Company’s Board of Directors. Options granted to date generally vest over four years from the date of grant. Stock option activity under the Plan was as follows:
| Options outstanding |  | Weighted average exercise price |  | Weighted average remaining contractual term
Balance as of January 29, 2022 | 39,763 |  |  | $ | 34.48 |  |  | 2.3
Exercised | (21,737) |  |  | 34.11 |  |
Balance as of January 28, 2023 | 18,026 |  |  | 34.92 |  | 1.8
Forfeited | (100) |  |  | 41.67 |  |
Exercised | (7,800) |  |  | 36.70 |  |
Balance as of February 3, 2024 | 10,126 |  |  | 33.48 |  | 1.6
Exercised | (10,126) |  |  | 33.48 |  |
Balance as of February 1, 2025 | — |  |  |  |  | — |
Exercisable as of February 1, 2025 | — |  |  |  |  | — |
| The fair value of each option award granted to crew, including outside directors, is estimated on the date of grant using the Black-Scholes option-pricing model. The Company did not grant any stock options in fiscal 2024, fiscal 2023 and fiscal 2022. The Company uses the simplified method to estimate the expected term of the option. The expected volatility incorporates historical and implied volatility of similar entities whose share prices are publicly available. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The total intrinsic value of stock options exercised during fiscal 2024, fiscal 2023 and fiscal 2022 was $0.6 million, $1.1 million and $3.1 million, respectively. There were no stock options outstanding and exercisable as of February 1, 2025. In fiscal 2024, fiscal 2023 and fiscal 2022, the Company received cash from the exercise of options of $0.3 million, $0.3 million and $0.8 million, respectively. Upon option exercise, the Company issued new shares of common stock.

X
- Definition Stock Option Plans [Text Block] + References No definition available. + Details
Name: | five_StockOptionPlansTextBlock
Namespace Prefix: | five_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration